Chronomodulated drug delivery system: A comprehensive review on the recent advances in a new sub-discipline of ‘chronopharmaceutics’
Main Article Content
Abstract
The mammalian circadian pacemaker resides in the paired suprachiasmatic nuclei and influences a multitude of biological processes, including the sleep–wake rhythm. Clock genes are the genes that control the circadian rhythms in physiology and behavior. Twenty-four hours rhythms are demonstrated for the function of physiology and the pathophysiology of diseases. The effectiveness and toxicity of many drugs vary depending on the dosing time. Such chronopharmacological phenomena are influenced by not only the pharmacodynamics, but also the pharmacokinetics of medications.The underlying
mechanisms are associated with the 24-hour rhythms of biochemical,physiological, and behavioral processes under thecontrol of the circadian clock. New technology for delivering medications precisely in a time-modulated fashion, by bedside or ambulatory pumps, is being developed to manage human diseases. From the point of view of pharmaceutics, the
application of a biological rhythm to pharmacotherapy may be accomplished by the appropriate timing of conventionally formulated tablets and capsules, and a special drug delivery system, to synchronize the drug concentrations with the
rhythms in the disease activity. Therefore, the present article gives an overview of the dosing time-dependent alterations in the therapeutic outcome and safety of the drug. The underlying mechanisms and usefulness are introduced from the
point of view of chronopharmacology and chronotherapy.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Halberg F, Stephens AN. Susceptibility to ouabain and physiologic
circadian periodicity. Proc Minn Acad Sci 1959;27:139-43.
Albrecht U, Sun ZS, Eichele G, Lee CC. A differential response of two
putative mammalian circadian regulators, mper1 and mper2, to light.
Cell 1997;91:1055-64.
Tei H, Okamura H, Shigeyoshi Y, Fukuhara C, Ozawa K, Hirose M, et al.
Circadian oscillation of a mammalian homologue of the Drosophila
period gene. Nature 1997;389:512-6.
Takumi T, Taguchi K, Miyake S, Sakakida Y, Takashima N, Matsubara C,
et al. A light independent oscillatory gene mPer3 in mouse SCN and
OVLT. EMBO J 1998;17:4753-9.
Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, King DP,
et al. Role of the CLOCK protein in the mammalian circadian mechanism.
Science 1998;280:1564-9.
Ikeda M, Nomura M. cDNA cloning and tissue-specific expression of a
novel basic helix–loop–helix/PAS protein (BMAL1) and identification of
alternatively spliced variants with alternative translation initiation site
usage. Biochem Biophys Res Commun 1997;233:258-64.
Sangoram AM, Saez L, Antoch MP, Gekakis N, Staknis D, Whiteley A,
et al. Mammalian circadian autoregulatory loop: A timeless ortholog
and mPER1 interact and negatively regulate CLOCKBMAL1- induced
transcription. Neuron 1998;21:1101-13.
Okamura H, Miyake S, Sumi Y, Yamaguchi S, Yasui A, Muijtjens M, et al.
Photic induction of mPer1 and mPer2 in Crydeficient mice lacking a
biological clock. Science 1999;286:2531-4.
Lowrey PL, Shimomura K, Antoch MP, Yamazaks S, Zemenides PD, Ralph MR, et al. Positional systemic cloning and functional characterization
of the mammalian circadian mutation tau. Science 2000;288:483-92.
Tei H, Okamura H, Shigeyoshi Y, Fukuhara C, Ozawa K, Hirose M, et al.
Circadian oscillation of a mammalian homologue of the Drosophila
period gene. Nature 1997;389:512-6.
Bussemer T, Peppas NA, Bodmeier R. Evaluation of the swelling,
hydration and rupturing properties of the swelling layer of a rupturable
pulsatile drug delivery system. Eur J Pharm. Biopharm 2003;56:261-70.
Martin RJ, Banks-Schlegel S. Chronobiology of asthma. Am J Respir Crit Care Med 1998;158:1002-7.
Bruguerolle B, Labrecque G. Rhythmic pattern in pain and their
chronotherapy. Adv Drug Deliv. Rev 2007;59:883-95.
Morta R, Jose L, Vila J. Design of new multiparticulate sysmem for
potential site-specific and controlled drug delivery to the colonic
region. J Contr Rel 1998;55:67-77.
Richard JM, Susan BS. Chronobiology of asthma. Am J Resp Crit Care
Med. 1998;158:1002-7. Available from: http://www.atsjournals.org.[Last
accessed on 2010 Dec 02].
Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzaniga A.
In vitro and in vivo evaluation of an oral system for time and/or site-
specific drug delivery. J Control Release 2001;73:103-10.
Mohamad A, Dashevsky A. pH-independent pulsatile drug delivery
system based on hard gelatin capsules and coated with aqueous
dispersion Aquacoat ECD. Eur J Pharm Biopharm 2006;64:173-9.
Gazzaniga A, Maroni A, Sangalli ME, Zema L. Time-controlled oral delivery systems for colon targeting. Exp Opin. Drug Deliv 2006;5:583-97.
Khan Z, Pillay V, Choonara YE, du Toit LC. Drug delivery technologies
for chronotherapeutic applications. Pharm Dev Technol 2009;14:602-12.
Saigal N, Baboota S, Ahuja A, Ali J. Multiple pulse drug delivery systems: Setting a new paradigm for infectious disease therapy. Expert Opin Drug Deliv 2009;6:441-52.
Sawada T, Sako K, Yoshihara K, Nakamura K, Yokohama S, Hayashi M.
Timed-release formulation to avoid drug–drug interaction between
diltiazem and midazolam. J Pharm Sci 2003;92:790-7.
Stevens H, Chariot M, Arnold F, Lewis G. Sustained release
pharmaceutical composition of diltiazem. U.S. patent 5112621, May
, 1992.
Halberg F. Chronobiology. Annu Rev Physiol 1969;31:675-725.
Reinberg A, Halberg F. Circadian chronopharmacology. Annu Rev
Pharmacol 1971;11:455-92.
Smolensky MH, Labrecque G. Chronotherapeutics. Pharm News
;4:10-6.
Ohdo S. Changes in toxicity and effectiveness with timing of drug
administration. Implications for drug safety. Drug Safety 2003;26:999-
Ohdo S. Chronopharmaceutics: Pharmaceutics focused on biological
rhythm. Biol Pharm Bull 2010;33:159-67.
Ohdo S. Chronopharmacology focused on biological clock. Drug Metab
Pharmacokinet 2007; 22:3-14.
Moore JG, Englert E Jr. Circadian rhythm of gastric acid secretion in
man. Nature 1970;226:1261-2.
Bloom PB, Filion RD, Stunkard AJ, Fox S, Stellar E. Gastric and duodenal
motility, food intake and hunger measured in man during a 24-h period.
Am J Dig Dis 1970;15:719-25.
Belanger P, Bruguerolle B, Labrecque G. Rhythms in pharmacokinetics:
Absorption, distribution, metabolism and excretion. In: Redfern PH,
Lemmer B, editors. Physiology and Pharmacology of Biological Rhythms.
Heidelberg: Springer-Verlag; 1997. p. 177-204.
Labrecque G, Belanger P. Biological rhythms in the absorption,
distribution, metabolism and excretion of drugs. Pharmacol Ther
;52:95-107.
Reinberg A, Smolensky M. Circadian changes of drug disposition in
man. Clin Pharmacokinet 1982;7:401-20.
Bruguerolle B. Chronopharmacokinetics: Current status. Clin
Pharmacokinet 1998;35:83-94.
Labrecque G, Belanger P. Biological rhythms in the absorption,
distribution, metabolism and excretion of drugs. Pharmacol Ther
;52:95-107.
Anderson NH, Devlin AM, Graham D, Morton JJ, Hamilton CA, Reid JL,
et al. Telemetry for cardiovascular monitoring in a pharmacological
study: New approaches to data analysis. Hypertension 1999;33:248-55.
Pleschka K, Heinrich A, Witte K, Lemmer B. Diurnal and seasonal
changes in sympathetic signal transduction in cardiac ventricles of
European hamsters. Am J Physiol 1996;270:304-9.
Bruguerolle B, Arnaud C, Levi F, Focan C, Touitou Y, Bouvenot G.
Physiopathological alterations of alpha 1 acid glycoprotein temporal
variations: Implications for chronopharmacology. In: Baumann P, C.B.
Chronobiol Int 2008; 25(1):1-15
Feuers RJ, Scheving LE. Chronobiology of hepatic enzymes. Ann Rev
Chronopharmacol 1988;4:209-54.
Belanger PM, Labrecque G. Temporal aspects of drug metabolism. In:
Lemmer B, editor. Chronopharmacology: Cellular and Biochemical
Interactions. Basel: Marcel Dekker; 1991. p. 15-34.
Ohno M, Yamaguchi I, Ito T, Saiki K, Yamamoto I, Azuma J.
Physiopathological alterations of alpha 1 acid glycoprotein temporal
variations: Implications for chronopharmacology. Circadian variation of
the urinary 6 beta-hydroxycortisol to cortisol ratio that would reflect
hepatic CYP3A activity. Eur J Clin Pharmacol 2000;55:861-5.
Cambar J, Cal JC, Tranchot J. Renal excretion: Rhythms in physiology and
pathology. In: Touitou Y, Physiopathological alterations of alpha 1 acid
glycoprotein temporal variations: Implications for chronopharmacology.
Haus E, editors. Biological Rhythms in Clinical and Laboratory Medicine.
Paris: Springer-Verlag; 1992. p. 470-82.
Detli L, Spring P. Diurnal variations in the elimination rate of
sulphonamide in man. Helv Med Acta 1966;4:921-926.
Sydenham T. The Works of Thomas Sydenham. Translated from the Latin
by Lathan RG, editor. Vol. 2. London, Sydenhm socity. 1850. p. 124.
Harris MD, Siegel LB, Alloway JA. Gout and hyperuricemia Am Fam
Phys 1999;59:925-34.
Rigas B, Torosis J, McDougall CJ, Vener KJ, Spiro HM. The circadian
rhythm of biliary colic. J Clin Gastroenterol 1990;12:409-14.
Moore JG, Halberg F. Circadian rhythm of gastric acid secretion in
active duodenal ulcer: Chronobiological statistical characteristics and
comparison of acid secretory and plasma gastrin patterns in healthy and
post-vagotomy and pyloroplasty patients. Chronobiol Int 1987;4:101-10.
Cugini P, Di Palma L, Battisti P, Leone G, Materia E, Parenzi A, et al.
circadian and infradian periodicity of some cardiovascular emergencies.
Am J Cardiol. 1990;66:240-243.
Kroetz CO, Ein biologiescher 24-Studen-Rhythmus des Blutkreislaufs
bei Gesundheit und bei Herzschivache zugleich ein Beitrag zur
tageszeitlichen Haufung einiger akuter Kreislaufstorunge. Munch Med
Wochenschr. 1940;87:314-7.
Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med
;85:6-8.
Bateman JR, Clark SW. Sudden death in asthma. Thorax 1979;34:40-4.
Kelmanson IA. Circadian variation of the frequency of sudden infant
death syndrome and of sudden death from life-threatening conditions
in infants. Chronobiologia 1991;18:181-6.
Reinberg AE, Gervais P, Levi F, Smolensky M, Del Cerro L, Ugolini C.
Circadian and circannual rhythms of allergic rhinitis: An epidemiologic
study involving chronobiologic methods. J Allergy Clin Immunol
;81:51-62.
Smolensky MH, Reinberg A, Labrecque G.Twenty-four hour pattern in
symptom intensity of viral and allergic rhinitis: Treatment implications.
J Allergy Clin Immunol 1995;95:1084-96.
Kowanko IC, Knapp MS, Pownall R, Swannell AJ. Domiciliary self
measurement in rheumatoid arthritis and the demonstration of
circadian rhythmicity. Ann Rheum Dis 1982;41:453-5.
Solomon GD. Circadian rhythms and migraine. Clevel Clin J Med
;59:326-9.
Dexter JD, Weizman ED. The relationship between nocturnal headaches
to sleep stage patterns. Neurology 1970;20:513-8.
Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, et al,
Circadian variation of transient myocardial ischemia in patients with
coronary artery disease. Circulation 1987;75:395-400.
Mulcahy D, Keegan J, Cunningham D, Quyyumi A, Crean P, Park A, et al,Circadian variation of total ischemic burden and its alteration with
anti-anginal agents. Lancet 1998;2:755-9.
Behrens S, Ehlers C, Brüggemann T, Ziss W, Dissmann R, Galecka M, et al.Modification of the circadian pattern of ventricular tachyarrthythmias
by beta-blocker therapy. Clin Cardiol1997;20:253-7.
Goldstein S, Zoble RG, Akiyama T, Cohen JD, Lancaster S, Liebson
PR, et al, Relation of circadian ventricular ectopic activity to cardiac
mortality CAST Investigators. Am J Cardiol 1996;78:881-5.
Venditti FJ Jr, John RM, Hull M, Tofler GH, Shahian DM, Martin DT.
Circadian variation in defibrillation energy requirements. Circulation
;94:1607-12.
Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA. Meta
analysis of the morning excess of acute myocardial infarction and
sudden cardiac death. Am J Cardiol 1997;79:1512-6.
Elliott WJ. Circadian variation in the timing of stoke onset. A meta
analysis. Stroke 1998;29:992-6.
Gallerani M, Manfredini R, Ricci L, Grandi E, Cappato R, Calò G. Sudden
death from pulmonary thromboembolism: Chronobiological aspects.
Eur Heart J 1992;6:305-23.
Gallerani M, Manfredini R, Fersini C. Chronoepidemiology in human
disease. Ann Inst Super Sanita 1993;29:569-79.
Portaluppi F, Manfredini R, Fersini C. From a static to a dynamic concept
of risk: The circadian epidemiology of cardiovascular risk. Chronobiol
Int 1999;16:33-50.
Wehr TA. Circadian rhythm disturbances in depression and mania. In:
Brown FM, Graeber RC, editors. Rhythmic Aspects of Behavior. New
Jerey. Lawrence Erlbaum Ass; 1982. p. 399-428.
Bellamy N, Sothern RB, Campbell J. Rhythmic variations in pain
perception in osteoarthritis of the knee. J Rheumatol 1990;
:364-72.
Folkard S. Diurnal variation and individual differences in the perception
of intractable pain. J Psychosom Res 1976;20:289-304.
Manfredini R, Gallerani M, Salmi R, Calò G, Pasin M, Bigoni M. Circadian
variation in the time of onset of acute intestinal bleeding. J Emerg
Med 1994;12:5-9.
Svanes C, Sothern RB, Sorbye H. Rhythmic patterns in incidence of
peptic ulcer perforation over 5.5 decades in Norway. Chronobiol Int
;15:241-264.
Langdon-Down M, Brain WR. Time of day in relation to convulsion in
epilepsy. Lancet 1929;12:1029-1032.
Baxil CW, Walczak TS. Effects of sleep and sleep stage on epileptic and
nonepileptic seizures. Epilepsia 1997;38:56-62.
Ohdo S, Koyanagi S, Suyama H, Higuchi S, Aramaki H. Changing the
dosing schedule minimizes the disruptive effects of interferon on clock
function. Nat Med 2001;7:356-60.
Youan BC. Chronopharmaceutics: Gimmick or clinically relevant
approach to drug delivery?. J Control Rel 2004;98:337-53.
Jao F, Wong P, Huynh H, McChesney K, Wat P. United States: Alza
Corporation. 1992. p. 17.
Verma R, Sanjay G. Current status of drug delivery technologies and
future directions. Pharm Technol 2001;25:1-14.
Leslie S. Euroceltique, SA, United States: 1982. p. 20.
Leslie S. The Contin delivery system: Dosing considerations. J Allergy
Clin Immunol 1986;78:768-73.
Arkinstall WW. Review of the North American experience with evening
administration of Uniphyl tablets, a once-daily theophylline preparation,
in the treatment of nocturnal asthma. Am J Med 1988;85:60-3.
Percel P, Vishnupad K, Venkatesh GM. Timed pulsatile drug delivery
systems. US Patent 6,627,223.
FDA. In: Electronic Orange Book. Washington, DC: Electronic Orange
Book; 2003.
Youan BC. Overview of chronopharmaceutics. In: Youan BC, Editor.
Chronopharmaceutics: Science and Technology for Biological Rhythm
Guided Therapy and Prevention of Diseases. Hoboken, NJ: John Wiley
and Sons, Inc; 2009.
Prisant LM, Devane JG, Butler J. A steady-state evaluation of the
bioavailability of chronopharmaceutic oral drug absorption system
verapamil PM after night time dosing versus immediate-acting
verapamil dosed every 8 h. Am J Ther 2000;7:345-51.
Panoz D, Geoghegan E. Elan Corporation, United States, 1989. p. 49.
Conte U, Maggi L. Modulation of the dissolution profiles from
Geomatrix® multilayer matrix tablets containing drugs of different
solubility. Biomoterials 1996;17:889-96.
Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Teung P, et al, Oral
dosage forms fabricated by three dimensional printing. J Control
Release 2000;66:1-9.
Rowe CW, Katstra WE, Palazzolo RD, Giritlioglu B, Teung P, et al,
Multimechanism oral dosage forms fabricated by three dimensional
printing. J Control Release 2000;66:11-7.
Monkhouse D, Yoo J, Sherwood J, Cima M, Bornancini E. Therics. United
States, 2003. p. 19.
Staniforth JN, Baichwal AR, TIMERx®: Novel polysaccharide composites
for controlled/programmed release of drugs in the gastrointestinal
tract. Expert Opin Drug Deliv 2005;2:587-95.
Horter D, Dressman JB. Influence of physicochemical properties on
dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev
;46:75-87.
Mahey R, Bersot T. Drug therapy for hypercholesterolemia and
dyslipidemia. In: Hardman J, Limbird L, Gilman A, editors. Goodman
and Gilman's The Pharmacological Basis of Therapeutics. New York:
McGraw-Hill; 2001.
Santini JT Jr, Cima MJ, Langer R. A controlled-release microchip. Nature
;397:335-8.
Santini JT Jr, Richards AC, Scheidt R, Cima MJ, Langer R. Microchips
as controlled drug-delivery devices. Angew Chem Int Ed Engl
;39:2396-407.
Sershen S, West J. Implantable, polymeric systems for modulated drug
delivery. Adv Drug Deliv 2002;54:1225-35.
Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy
with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal
cancer. International Organization for Cancer Chronotherapy. Lancet
;350:681-6.
Remeling R, Hrushesky WJ. Circadian patterning of continuous
floxuridine infusion reduces toxicity and allows higher dose intensity
in patients with widespread cancer. J Clin Oncol 1989;7:1710-9.
Tzannis ST, Hrushesky WJ, Wood PA, Przybycien TM. Irreversible
inactivation of interleukin 2 in a pump-based delivery environment.
Proc Natl Acad Sci USA 1996;93:5460-5.